BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32160053)

  • 1. Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle.
    Lee CH; Bryce Y; Zheng J; Sung JS; Comstock CE; Moskowitz C; A Morris E
    AJR Am J Roentgenol; 2020 May; 214(5):1175-1181. PubMed ID: 32160053
    [No Abstract]   [Full Text] [Related]  

  • 2. Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition.
    Kang SS; Ko EY; Han BK; Shin JH; Hahn SY; Ko ES
    J Magn Reson Imaging; 2014 Mar; 39(3):526-34. PubMed ID: 23633296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women.
    Dontchos BN; Rahbar H; Partridge SC; Lehman CD; DeMartini WB
    J Breast Imaging; 2019 Sep; 1(3):205-211. PubMed ID: 31538142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging.
    Kajihara M; Goto M; Hirayama Y; Okunishi S; Kaoku S; Konishi E; Shinkura N
    Magn Reson Med Sci; 2013 Mar; 12(1):39-45. PubMed ID: 23474960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women.
    He Y; Zhou J; Liu X; Wei Y; Ye S; Miao H; Liu H; Chen Z; Zhao Y; Wang M
    Clin Breast Cancer; 2023 Oct; 23(7):e451-e457.e1. PubMed ID: 37640598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and Cancer Yield of BI-RADS Category 3 Lesions Detected at High-Risk Screening Breast MRI.
    Edmonds CE; Lamb LR; Mercaldo SF; Sippo DA; Burk KS; Lehman CD
    AJR Am J Roentgenol; 2020 Feb; 214(2):240-248. PubMed ID: 31799867
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.
    Amarosa AR; McKellop J; Klautau Leite AP; Moccaldi M; Clendenen TV; Babb JS; Zeleniuch-Jacquotte A; Moy L; Kim S
    Radiology; 2013 Aug; 268(2):356-65. PubMed ID: 23657893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of screening mammography varies by week of menstrual cycle.
    Miglioretti DL; Walker R; Weaver DL; Buist DS; Taplin SH; Carney PA; Rosenberg RD; Dignan MB; Zhang ZT; White E
    Radiology; 2011 Feb; 258(2):372-9. PubMed ID: 21131584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
    Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
    Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Diagnostic Accuracy of Mammogram-based Deep Learning and Traditional Breast Cancer Risk Models in Patients Who Underwent Supplemental Screening with MRI.
    Lamb LR; Mercaldo SF; Ghaderi K; Carney A; Lehman CD
    Radiology; 2023 Sep; 308(3):e223077. PubMed ID: 37724967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting Nonmass Enhancement in Breast MRI: Analysis of Outcomes and Follow-Up Using the Updated BI-RADS Atlas.
    Chikarmane SA; Michaels AY; Giess CS
    AJR Am J Roentgenol; 2017 Nov; 209(5):1178-1184. PubMed ID: 28834447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of background parenchymal enhancement (BPE) on contrast-enhanced cone-beam breast CT (CE-CBBCT) and breast MRI.
    Ma Y; Liu A; Zhang Y; Zhu Y; Wang Y; Zhao M; Liang Z; Qu Z; Yin L; Lu H; Ye Z
    Eur Radiol; 2022 Aug; 32(8):5773-5782. PubMed ID: 35320411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
    Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
    AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Clinical Factors and Degree of Early Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
    Wang S; Sun Y; You C; Jiang T; Yang M; Shen X; Qian M; Duan S; Lynn HS; Li R; Gu Y
    AJR Am J Roentgenol; 2023 Jul; 221(1):45-55. PubMed ID: 36695647
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast Cancer Screening with Abbreviated Breast MRI: 3-year Outcome Analysis.
    Kwon MR; Choi JS; Won H; Ko EY; Ko ES; Park KW; Han BK
    Radiology; 2021 Apr; 299(1):73-83. PubMed ID: 33620293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of abbreviated breast MRI for screening of women with previously treated breast cancer.
    Kwon MR; Ko EY; Han BK; Ko ES; Choi JS; Park KW
    Medicine (Baltimore); 2020 Apr; 99(16):e19676. PubMed ID: 32311941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle.
    Ellis RL
    AJR Am J Roentgenol; 2009 Dec; 193(6):1738-40. PubMed ID: 19933673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population.
    Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiragami N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
    Eur J Radiol; 2019 Jan; 110():130-135. PubMed ID: 30599849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Screening Breast MRI After Negative Full-Field Digital Mammography Versus After Negative Digital Breast Tomosynthesis in Women at Higher Than Average Risk for Breast Cancer.
    Roark AA; Dang PA; Niell BL; Halpern EF; Lehman CD
    AJR Am J Roentgenol; 2019 Feb; 212(2):271-279. PubMed ID: 30540208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.